Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$304K 5164
2022
Q3
$304K Buy
+10,000
New +$343K ﹤0.01% 3340
2019
Q1
Sell
-4,200
Closed -$198K 4578
2018
Q4
$198K Sell
4,200
-18,600
-82% -$1.12M ﹤0.01% 3040
2018
Q3
$1.7M Buy
+22,800
New +$1.57M 0.01% 1553

Other funds holding SRDX

PEAK6 Investments's SRDX Position: Q4 2022 in Review

PEAK6 Investments sold out of Surmodics (SRDX) in Q4 2022, closing a stake of 5,221 shares — an estimated $159K sold.

PEAK6 Investments first reported a position in SRDX in Q4 2018 and held it in 2 quarters. The position peaked at $159K in Q3 2022. 122 funds tracked by Wall St. Rank hold SRDX as of Q4 2022.

  • PEAK6 Investments reported no remaining Surmodics position as of Q4 2022 after selling out during the quarter.
  • PEAK6 Investments sold 5,221 Surmodics shares in Q4 2022, an estimated $159K.
  • PEAK6 Investments first reported a position in Surmodics in Q4 2018 and held it in 2 quarters.
  • PEAK6 Investments's Surmodics position peaked at $159K in Q3 2022.
  • 122 funds tracked by Wall St. Rank held Surmodics as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.